Adimab Inside: Polaris, Orbimed Back Antibody Attack On Novel Alzheimer’s Biology
This article was originally published in The Pink Sheet Daily
Executive Summary
Alzheimer’s-focused Alector combines its scientific founders’ biological insight with antibody discovery technology from Adimab, allowing Adimab’s backers and executives to pursue multiple but distinct bets on the success of their platform.